Cargando…
Corporate social responsibility to improve access to medicines: the case of Brazil
BACKGROUND: Access to medicines and the development of a strong national pharmaceutical industry are two longstanding pillars of health policy in Brazil. This is reflected in a clear emphasis by Brazil’s Federal Government on improving access to medicine in national health plans and industrial polic...
Autores principales: | Thorsteinsdóttir, Halla, Ovtcharenko, Natasha, Kohler, Jillian Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320638/ https://www.ncbi.nlm.nih.gov/pubmed/28222793 http://dx.doi.org/10.1186/s12992-017-0235-7 |
Ejemplares similares
-
The make or buy debate: Considering the limitations of domestic production in Tanzania
por: Wilson, Kinsley Rose, et al.
Publicado: (2012) -
Canada's Neglected Tropical Disease Research Network: Who's in the Core—Who's on the Periphery?
por: Phillips, Kaye, et al.
Publicado: (2013) -
Why the MDGs need good governance in pharmaceutical systems to promote global health
por: Kohler, Jillian Clare, et al.
Publicado: (2014) -
Improving Access to Medicines in Low and Middle Income Countries: Corporate Responsibilities in Context
por: Leisinger, Klaus Michael, et al.
Publicado: (2012) -
An examination of pharmaceutical systems in severely disrupted countries
por: Kohler, Jillian Clare, et al.
Publicado: (2012)